Quick Answer
Imunon, Inc. reported Operating Income of -$14.65 million for fiscal year 2025.
Imunon, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$14.65M | +23.4% |
| 2024 | -$19.13M | +9.0% |
| 2023 | -$21.03M | +15.6% |
| 2022 | -$24.92M | -18.6% |
| 2021 | -$21.01M | -13.6% |
| 2020 | -$18.49M | +10.1% |
| 2019 | -$20.57M | +2.4% |
| 2018 | -$21.07M | -14.1% |
| 2017 | -$18.47M | +10.6% |
| 2016 | -$20.65M | +0.9% |
| 2015 | -$20.85M | +15.7% |
| 2014 | -$24.72M | -60.4% |
| 2013 | -$15.41M | +30.4% |
| 2012 | -$22.14M | +3.8% |
| 2011 | -$23.02M | -17.2% |
| 2010 | -$19.64M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.48M | +29.9% | -25.6% |
| June 30, 2025 | -$2.77M | +44.8% | +33.2% |
| March 31, 2025 | -$4.15M | +17.3% | +16.5% |
| September 30, 2024 | -$4.96M | -27.1% | +1.0% |
| June 30, 2024 | -$5.01M | +8.4% | -0.0% |
| March 31, 2024 | -$5.01M | +11.8% | -28.4% |
| September 30, 2023 | -$3.90M | +36.8% | +28.7% |
| June 30, 2023 | -$5.47M | +8.4% | +3.7% |
- Imunon, Inc. showed an increase of +23.4% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, Imunon, Inc.’s operating income has grown by 25.4% (from -$19.64 million to -$14.65 million).
- The most recent figure is from Imunon, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: